Skip to main content

Table 1 Summary of differences in renal function outcomes between non-buffered and buffered fluid groups

From: Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic review

Outcomes

Absolute effects

No. of participants (studies)

p

Outcome with non-buffered fluid (mean)

Outcome with buffered fluid (mean; mean difference with 95% CI)

Urine output—intraoperative

799 ml

872 ml (MD 6.1 ml higher; 95% CI − 128.4 to 140.6)

459 (8 RCTs)

0.93

Creatine change—postoperative

MD in creatinine was 7.0 μmol/L lower in the buffered fluids group; 95% CI − 27.4 to 13.5

113 (2 RCTs)

0.50

Creatine change—postoperative day 1

MD in creatinine was 4.9 μmol/L lower in the buffered fluids group; 95% CI − 5.9 to 15.8

113 (2 RCTs)

0.37

Creatinine—postoperative

Non-transplant patients

127 (2 RCTs)

0.59

79.5 μmol/L

76.2 μmol/L (MD 2.38 μmol/L lower; 95% CI − 10.98 to 6.23)

Renal transplant patients

110 (1 RCT)

0.01

460 μmol/L

530 μmol/L (MD 70 μmol/L higher; 95% CI 14.31 to 125.69)

Creatinine—postoperative day 1

Non-transplant patients

61 (1 RCT)

0.44

80 μmol/L

86 μmol/L (MD 6 μmol/L higher; 95% CI − 21.23 to 9.23)

Renal transplant patients

150 (2 RCTs)

0.74

353.5 μmol/L

336 μmol/L (MD 12.26 μmol/L lower; 95% CI − 85.10 to 60.57)

Creatinine—postoperative day 3

Renal transplant patients

301 (4 RCTs)

0.98

168 μmol/L

173 μmol/L (MD 0.47 μmol/L higher; 95% CI − 30.12 to 29.19)